ID

22314

Beschrijving

XELODA and Lapatinib Advanced or Metastatic Breast Cancer Study ID: 100151 Clinical Study ID: EGF100151 Study Title: A Phase III, Randomized, Open-label, Multicenter Study Comparing GW572016 and Capecitabine (XELODA) versus Capecitabine in Women with Refractory Advanced or Metastatic Breast Cancer Clinicaltrials.gov Identifier: NCT00078572 https://clinicaltrials.gov/ct2/show/NCT00078572 Procedure: Concomitant Medications Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: lapatinib Trade Name: Tyverb,Tykerb,Tycerb Study Indication: Breast Cancer; Neoplasms, Breast

Link

https://clinicaltrials.gov/ct2/show/NCT00078572

Trefwoorden

Versies (1)
  1. 29-05-17 29-05-17 -
Geüploaded op

29 mei 2017

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY-NC 3.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

XELODA and Lapatinib Advanced or Metastatic Breast Cancer Concomitant Medications NCT00078572

Engels

XELODA and Lapatinib Advanced or Metastatic Breast Cancer Concomitant Medications NCT00078572

1 Formulieren  
Concomitant Medications
Beschrijving

Concomitant Medications

Alias
UMLS CUI-1
C2347852
Drug, Trade name preferred
Beschrijving

Drug

Datatype

text

Alias
UMLS CUI [1,1]
C2347852
UMLS CUI [1,2]
C2360065
Date started
Beschrijving

Date started

Datatype

date

Alias
UMLS CUI [1,1]
C0808070
UMLS CUI [1,2]
C2347852
Check if started Pre-study
Beschrijving

started Pre-study

Datatype

text

Alias
UMLS CUI [1]
C2347852
Date stopped
Beschrijving

Date stopped

Datatype

date

Alias
UMLS CUI [1,1]
C0806020
UMLS CUI [1,2]
C2347852
Check if continued Post- study
Beschrijving

continued Post- study

Datatype

text

Alias
UMLS CUI [1]
C2347852
Conditions treated/ indication
Beschrijving

Conditions treated or indication

Datatype

text

Alias
UMLS CUI [1,1]
C3146298
UMLS CUI [1,2]
C2347852
Terug naar het begin van de pagina

Similar models

XELODA and Lapatinib Advanced or Metastatic Breast Cancer Concomitant Medications NCT00078572

1 Formulieren
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
Concomitant Medications
C2347852 (UMLS CUI-1)
Drug
Item
Drug, Trade name preferred
text
C2347852 (UMLS CUI [1,1])
C2360065 (UMLS CUI [1,2])
Date started
Item
Date started
date
C0808070 (UMLS CUI [1,1])
C2347852 (UMLS CUI [1,2])
Item
Check if started Pre-study
text
C2347852 (UMLS CUI [1])
started Pre-study
Code List
Check if started Pre-study
CL Item
Yes (Y)
CL Item
No (N)
Date stopped
Item
Date stopped
date
C0806020 (UMLS CUI [1,1])
C2347852 (UMLS CUI [1,2])
Item
Check if continued Post- study
text
C2347852 (UMLS CUI [1])
started Pre-study
Code List
Check if continued Post- study
CL Item
Yes (Y)
CL Item
No (N)
Conditions treated or indication
Item
Conditions treated/ indication
text
C3146298 (UMLS CUI [1,1])
C2347852 (UMLS CUI [1,2])
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial